NCT03291197View on ClinicalTrials.gov

Tolerability of Suprascapular and Median Nerve Blocks for the Treatment of Shoulder-hand Syndrome

PHASE4CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

October 15, 2017

Primary Completion Date

October 14, 2018

Study Completion Date

October 14, 2018

Conditions
Shoulder Hand SyndromeComplex Regional Pain Syndromes
Interventions
DRUG

Suprascapular and median nerve blocks

Ultrasound guided injection of the median and suprascapular nerve of the affected side.

Trial Locations (1)

K1N5C8

Elisabeth Bruyere Hospital, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER